Beta Bionics (BBNX) Inventory Average (2025 - 2026)
Beta Bionics recorded quarterly Inventory Average of $22.7 million in Q1 2026, up 7.97% quarter-over-quarter from $21.0 million in Q4 2025, and up 56.45% year-over-year from $14.5 million in Q1 2025.
Beta Bionics' Inventory Average history runs 2 years deep, the most recent figure standing at $22.7 million for Q1 2026.
- In Q1 2026, Inventory Average rose 56.45% year-over-year to $22.7 million; the TTM figure through Mar 2026 stood at $22.7 million (up 56.45% YoY), while the FY2025 annual figure was $17.5 million, up 140.59% from the prior year.
- Inventory Average came in at $22.7 million for Q1 2026 at Beta Bionics, up from $21.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $22.7 million in Q1 2026 to a low of $14.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 652.65 Mn |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | 22.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.72 Mn |
| Dec 31, 2025 | 21.05 Mn |
| Sep 30, 2025 | 18.85 Mn |
| Jun 30, 2025 | 16.53 Mn |
| Mar 31, 2025 | 14.53 Mn |